View drug registration information details.
Items | Registration information |
ID | 1218 |
No | 1218 |
Brand Name | MANORIFCIN |
Ingredients | RIFAMPICIN 300 MG |
Dosage Form | CAPSULE |
Primary Packaging | VIAL |
Storage | STORE BELOW 30C |
Shelf Life | 4 YEARS |
Pack Size | 3 CAPSULES/VIAL, BOX OF 5 VIALS |
Dispensing Category | Prescription only |
ATC Classification | |
Pharmaceutical Class | ANTITUBERCOLOSIS |
Indications | AN ANTIBIOTIC WHICH IS EFFECTIVE AGAINST TUBERCULOSIS, GONORRHEA MAY BE ACTIVE WHEN RESISTANCE TO OTHER DRUGS HAS DEVELOPED MANORIFCIN IS EXCRETED IN THE BILE SO IT HAS BEEN USED TO TREAT BILIARY INFECTION |
Contraindications | PRESENCE OF JAUNDICE AND IN PATIENTS WHO ARE HYPERSENSITIVE SUBSTANCE |
Side Effects | THROMBOCYTOPENIA, HEADACHE, DIZZINESS, NAUSEA, VOMITING, PYREXIA, CHILLS |
Unit Price | |
EDL |
Yes |
Description | RED CAPSULE |
Note | |
License Owner | KEOSILA PHARMA IMPORT-EXPORT CO.,LTD |
Manufacturer | LAMTHONG KARNPAT PHARMACEUTICAL FACTORY CO.,LTD |
Country | THAILAND |
Import Registration No | 1A 1117/29 |
Import Registration Date | 1986-05-29 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-01-14 |
FDD Registration No | 08 I 5261/22 |
FDD Registration Date | 2022-08-26 |
Expiry Date | 2025-08-25 |
Back to drug list
|